View in EDS HTML Full Text PDF Full Text

Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER).

Saved in:
Bibliographic Details
Title: Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER).
Authors: Spring LM; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Scarpetti L; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Medford AJ; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Niemierko A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Comander A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Mulvey T; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Schnipper L; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Isakoff SJ; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Moy B; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Wander SA; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Shin J; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Ephrem Z; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Laposta AR; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Denault E; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Abraham E; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Calistro G; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Kalashnikova E; Natera Inc., Austin, TX, USA., Rodriguez A; Natera Inc., Austin, TX, USA., Liu MC; Natera Inc., Austin, TX, USA., Aleshin A; Natera Inc., Austin, TX, USA., Peppercorn J; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Ellisen LW; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. abardia@mednet.ucla.edu.; University of California Los Angeles, Los Angeles, USA. abardia@mednet.ucla.edu.
Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Jan 07; Vol. 11 (1), pp. 2. Date of Electronic Publication: 2025 Jan 07.
Publication Type: Journal Article
Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39774684
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Spring+LM%22">Spring LM</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Scarpetti+L%22">Scarpetti L</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Medford+AJ%22">Medford AJ</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Niemierko+A%22">Niemierko A</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Comander+A%22">Comander A</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Mulvey+T%22">Mulvey T</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Schnipper+L%22">Schnipper L</searchLink>; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Isakoff+SJ%22">Isakoff SJ</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Moy+B%22">Moy B</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wander+SA%22">Wander SA</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shin+J%22">Shin J</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ephrem+Z%22">Ephrem Z</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Laposta+AR%22">Laposta AR</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Denault+E%22">Denault E</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Abraham+E%22">Abraham E</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Calistro+G%22">Calistro G</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kalashnikova+E%22">Kalashnikova E</searchLink>; Natera Inc., Austin, TX, USA.<br /><searchLink fieldCode="AU" term="%22Rodriguez+A%22">Rodriguez A</searchLink>; Natera Inc., Austin, TX, USA.<br /><searchLink fieldCode="AU" term="%22Liu+MC%22">Liu MC</searchLink>; Natera Inc., Austin, TX, USA.<br /><searchLink fieldCode="AU" term="%22Aleshin+A%22">Aleshin A</searchLink>; Natera Inc., Austin, TX, USA.<br /><searchLink fieldCode="AU" term="%22Peppercorn+J%22">Peppercorn J</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ellisen+LW%22">Ellisen LW</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bardia+A%22">Bardia A</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. abardia@mednet.ucla.edu.; University of California Los Angeles, Los Angeles, USA. abardia@mednet.ucla.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101674891%22">NPJ breast cancer</searchLink> [NPJ Breast Cancer] 2025 Jan 07; Vol. 11 (1), pp. 2. <i>Date of Electronic Publication: </i>2025 Jan 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Breast+Cancer+Research+Foundation%22">Breast Cancer Research Foundation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101674891 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2374-4677 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223744677%22">23744677 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Breast Cancer <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39774684
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41523-024-00708-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2
    Titles:
      – TitleFull: Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Spring LM
      – PersonEntity:
          Name:
            NameFull: Scarpetti L
      – PersonEntity:
          Name:
            NameFull: Medford AJ
      – PersonEntity:
          Name:
            NameFull: Niemierko A
      – PersonEntity:
          Name:
            NameFull: Comander A
      – PersonEntity:
          Name:
            NameFull: Mulvey T
      – PersonEntity:
          Name:
            NameFull: Schnipper L
      – PersonEntity:
          Name:
            NameFull: Isakoff SJ
      – PersonEntity:
          Name:
            NameFull: Moy B
      – PersonEntity:
          Name:
            NameFull: Wander SA
      – PersonEntity:
          Name:
            NameFull: Shin J
      – PersonEntity:
          Name:
            NameFull: Ephrem Z
      – PersonEntity:
          Name:
            NameFull: Laposta AR
      – PersonEntity:
          Name:
            NameFull: Denault E
      – PersonEntity:
          Name:
            NameFull: Abraham E
      – PersonEntity:
          Name:
            NameFull: Calistro G
      – PersonEntity:
          Name:
            NameFull: Kalashnikova E
      – PersonEntity:
          Name:
            NameFull: Rodriguez A
      – PersonEntity:
          Name:
            NameFull: Liu MC
      – PersonEntity:
          Name:
            NameFull: Aleshin A
      – PersonEntity:
          Name:
            NameFull: Peppercorn J
      – PersonEntity:
          Name:
            NameFull: Ellisen LW
      – PersonEntity:
          Name:
            NameFull: Bardia A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 01
              Text: 2025 Jan 07
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2374-4677
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ breast cancer
              Type: main
ResultId 1